Xofluza CR Exemption Set for Commission Vote

Commissioners' votes were due near the PSL deadline on approving a final rule to exempt certain packages of baloxavir marboxil (Xofluza) from the Poison Prevention Packaging Act. Affected would be ... Log in to view full article.

Already a subscriber?

Email: REQUIRED

Password: REQUIRED

Forgot your password? Click here to have your password emailed to you.

NOT YET A MEMBER?

Purchase a Membership
with a money-back guarantee
and immediate access